Thus, we investigated Stathmin 1 expression in PB CD34+ cells from healthy donors and patients with PV, ET and PMF and we also stratified the MPN patients according to the presence, or not, of JAK2V617F and CALR mutations. The gene discussed is STMN1; the disease is essential thrombocythemia.